Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alvaro Moreno

Showing results (11-20 of 129) with videos related to

Pageof 13
Sort By:
Breast Cancer : Basic and Clinical Research|December 17, 2011
Efficacy of bevacizumab-capecitabine in combination for the first-line treatment of metastatic breast cancerStephen Dyar, Alvaro Moreno-Aspitia
Artificial Life|July 13, 2004
Basic autonomy as a fundamental step in the synthesis of lifeKepa Ruiz-Mirazo, Alvaro Moreno
Breast Cancer (Dove Medical Press)|May 17, 2014
Current strategies for the prevention of breast cancerPooja Advani, Alvaro Moreno-Aspitia
Future Oncology (London, England)|March 25, 2006
Nanoparticle albumin-bound paclitaxel (ABI-007): a newer taxane alternative in breast cancerAlvaro Moreno-Aspitia, Edith A Perez
Bio Systems|August 28, 2007
The autonomy of biological individuals and artificial modelsAlvaro Moreno, Arantza Etxeberria, Jon Umerez
Acta Biotheoretica|August 21, 2020
Functional Integration and Individuality in Prokaryotic Collective OrganisationsGuglielmo Militello, Leonardo Bich, Alvaro Moreno
Acta Biotheoretica|February 4, 2019
An Organisational Approach to Biological CommunicationRamiro Frick, Leonardo Bich, Alvaro Moreno
Frontiers in Psychology|December 19, 2019
Revising the Superorganism: An Organizational Approach to Complex EusocialityMark Canciani, Argyris Arnellos, Alvaro Moreno
Mayo Clinic Proceedings|June 2, 2009
Treatment options for breast cancer resistant to anthracycline and taxaneAlvaro Moreno-Aspitia, Edith A Perez
Clinical Therapeutics|October 8, 2009
Anthracycline- and/or taxane-resistant breast cancer: results of a literature review to determine the clinical challenges and current treatment trendsAlvaro Moreno-Aspitia, Edith A Perez
Pageof 13

Showing results (11-20 of 129) with videos related to

Sort By:
Pageof 13
Breast Cancer : Basic and Clinical Research|December 17, 2011
Efficacy of bevacizumab-capecitabine in combination for the first-line treatment of metastatic breast cancerStephen Dyar, Alvaro Moreno-Aspitia
Artificial Life|July 13, 2004
Basic autonomy as a fundamental step in the synthesis of lifeKepa Ruiz-Mirazo, Alvaro Moreno
Breast Cancer (Dove Medical Press)|May 17, 2014
Current strategies for the prevention of breast cancerPooja Advani, Alvaro Moreno-Aspitia
Future Oncology (London, England)|March 25, 2006
Nanoparticle albumin-bound paclitaxel (ABI-007): a newer taxane alternative in breast cancerAlvaro Moreno-Aspitia, Edith A Perez
Bio Systems|August 28, 2007
The autonomy of biological individuals and artificial modelsAlvaro Moreno, Arantza Etxeberria, Jon Umerez
Acta Biotheoretica|August 21, 2020
Functional Integration and Individuality in Prokaryotic Collective OrganisationsGuglielmo Militello, Leonardo Bich, Alvaro Moreno
Acta Biotheoretica|February 4, 2019
An Organisational Approach to Biological CommunicationRamiro Frick, Leonardo Bich, Alvaro Moreno
Frontiers in Psychology|December 19, 2019
Revising the Superorganism: An Organizational Approach to Complex EusocialityMark Canciani, Argyris Arnellos, Alvaro Moreno
Mayo Clinic Proceedings|June 2, 2009
Treatment options for breast cancer resistant to anthracycline and taxaneAlvaro Moreno-Aspitia, Edith A Perez
Clinical Therapeutics|October 8, 2009
Anthracycline- and/or taxane-resistant breast cancer: results of a literature review to determine the clinical challenges and current treatment trendsAlvaro Moreno-Aspitia, Edith A Perez
Pageof 13